Endothelin-1 inhibits prostate cancer growth in vivo through vasoconstriction of tumor-feeding arterioles

Cancer Biology and Therapy

Volumn 8, Issue 8, 2009, Pages 720-729

  Weydert, Christine J ^a   Esser, Alison K ^a   Mejia, Ruth A ^a   Drake, Justin M ^a   Barnes, J Matthew ^a   Henry, Michael D ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b Molecular Physiology and Biophysics   (United States)

Author keywords

Endothelin 1; Metastasis; Prostate cancer; Tumor arteriole; Vasoconstriction

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; METASTASIS; MITOGENESIS; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; VASOCONSTRICTION;

EID: 66149121420     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.8.7922     Document Type: Article

References (36)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415 (Pubitemid 18090241)
2. Nelson JB, Hedican SP, George DJ, Reddi AH, Piantadosi S, Eisenberger MA, et al. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1995; 1:944-949
3. Nelson J, Bagnato A, Battistini B, Nisen P. The endothelin axis: emerging role in cancer. Nat Rev Cancer 2003; 3:110-116 (Pubitemid 37328878)
4. Masaki T. Historical review: endothelin. Trends Pharmacol Sci 2004; 25:219-224 (Pubitemid 38519913)
5. Nelson JB, Nguyen SH, Wu-Wong JR, Opgenorth TJ, Dixon DB, Chung LW, et al. New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade. Urology 1999; 53:1063-1069 (Pubitemid 29196330)
6. Yin JJ, Mohammad KS, Kakonen SM, Harris S, Wu-Wong JR, Wessale JL, et al. A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. Proc Natl Acad Sci USA 2003; 100:10954-10959 (Pubitemid 37140134)
7. Remuzzi G, Perico N, Benigni A. New therapeutics that antagonize endothelin: promises and frustrations. Nat Rev Drug Discov 2002; 1:986-1001. (Pubitemid 37361604)
8. Carducci MA, Saad F, Abrahamsson PA, Dearnaley DP, Schulman CC, North SA, et al. A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer. Cancer 2007; 110:1959-1966 (Pubitemid 350036854)
9. James ND, Caty A, Borre M, Zonnenberg BA, Beuzeboc P, Morris T, et al. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormoneresistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial. Eur Urol 2008.
10. Nambi P, Mattern MR, Wu HL, Pullen M, Nuthulaganti P, Hofmann GA, et al. Absence of endothelin receptors and receptor mRNA in mammalian fibroblasts transformed with SV40 or ras oncogene. Mol Cell Biochem 1997; 175:29-35. (Pubitemid 27453332)
11. Kusuhara M, Yamaguchi K, Nagasaki K, Hayashi C, Suzaki A, Hori S, et al. Production of endothelin in human cancer cell lines. Cancer Res 1990; 50:3257-3261 (Pubitemid 20190127)
12. Bagnato A, Tecce R, Moretti C, Di Castro V, Spergel D, Catt KJ. Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells. Clin Cancer Res 1995; 1:1059-1066
13. Ali H, Loizidou M, Dashwood M, Savage F, Sheard C, Taylor I. Stimulation of colorectal cancer cell line growth by ET-1 and its inhibition by ET(A) antagonists. Gut 2000; 47:685-688
14. Kusuhara M, Yamaguchi K, Ohnishi A, Abe K, Kimura S, Oono H, et al. Endothelin potentiates growth factor-stimulated DNA synthesis in Swiss 3T3 cells. Jpn J Cancer Res 1989; 80:302-305 (Pubitemid 20035980)
15. Drake JM, Gabriel CL, Henry MD. Assessing tumor growth and distribution in a model of prostate cancer metastasis using bioluminescence imaging. Clin Exp Metastasis 2005; 22:674-684 (Pubitemid 44259528)
16. Henry MD, Silva MD, Wen S, Siebert E, Solin E, Chandra S, et al. Spiculated periosteal response induced by intraosseous injection of 22Rv1 prostate cancer cells resembles subset of bone metastases in prostate cancer patients. Prostate 2005; 65:347-354 (Pubitemid 41759967)
17. Ablad B. A study of the mechanism of the hemodynamic effects of hydralazine in man. Acta Pharmacol Toxicol 1963; 20:1-53.
18. Mawji IA, Robb GB, Tai SC, Marsden PA. Role of the 3′-untranslated region of human endothelin-1 in vascular endothelial cells. Contribution to transcript lability and the cellular heat shock response. J Biol Chem 2004; 279:8655-8667 (Pubitemid 38295921)
19. Brown KD, Littlewood CJ. Endothelin stimulates DNA synthesis in Swiss 3T3 cells. Synergy with polypeptide growth factors. Biochem J 1989; 263:977-980
20. Vacca F, Bagnato A, Catt KJ, Tecce R. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells. Cancer Res 2000; 60:5310-5317
21. Nelson JB, Udan MS, Guruli G, Pflug BR. Endothelin-1 inhibits apoptosis in prostate cancer. Neoplasia 2005; 7:631-637 (Pubitemid 41099416)
22. Wu-Wong JR, Chiou WJ, Dickinson R, Opgenorth TJ. Endothelin attenuates apoptosis in human smooth muscle cells. Biochem J 1997; 328:733-737 (Pubitemid 28005768)
23. Morbidelli L, Orlando C, Maggi CA, Ledda F, Ziche M. Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors. Am J Physiol 1995; 269:686-695
24. Salani D, Taraboletti G, Rosano L, Di Castro V, Borsotti P, Giavazzi R, Bagnato A. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 2000; 157:1703-1711
25. Spinella F, Rosano L, Di Castro V, Natali PG, Bagnato A. Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. J Biol Chem 2002; 277:27850-27855
26. Wulfing P, Kersting C, Tio J, Fischer RJ, Wulfing C, Poremba C, et al. Endothelin-1-, endothelin- A- and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. Clin Cancer Res 2004; 10:2393-2400 (Pubitemid 38445698)
27. Salani D, Di Castro V, Nicotra MR, Rosano L, Tecce R, Venuti A, et al. Role of endothelin- 1 in neovascularization of ovarian carcinoma. Am J Pathol 2000; 157:1537-1547
28. Sonveaux P, Dessy C, Martinive P, Havaux X, Jordan BF, Gallez B, et al. Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment. Cancer Res 2004; 64:3209-3214 (Pubitemid 38581424)
29. Ferrero Herrero E, Garcia Villalon AL, Labalde Martinez M, Dieguez Castrillo G, Hidalgo Pascual M. Effect of endothelin-1 on tumor arteries in patients with colorectal cancer. Rev Esp Enferm Dig 2008; 100:327-331
30. Langenstroer P, Tang R, Shapiro E, Divish B, Opgenorth T, Lepor H. Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies. J Urol 1993; 150:495-499 (Pubitemid 23215911)
31. Casey ML, Byrd W, MacDonald PC. Massive amounts of immunoreactive endothelin in human seminal fluid. J Clin Endocrinol Metab 1992; 74:223-225
32. Grant ES, Brown T, Roach A, Williams BC, Habib FK. In vitro expression of endothelin-1 (ET-1) and the ETA and ETB ET receptors by the prostatic epithelium and stroma. J Clin Endocrinol Metab 1997; 82:508-513
33. Wu-Wong JR. Using receptor antagonists in binding studies to characterize a mammalian endothelin receptor. In: Maguire JJ, Davenport AP, eds. Peptide research protocols endothelin. Totowa, New Jersey: Humana Press 2002; 71-91.
34. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143:401-409 (Pubitemid 24058195)
35. Ljungkvist AS, Bussink J, Rijken PF, Kaanders JH, van der Kogel AJ, Denekamp J. Vascular architecture, hypoxia and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2002; 54:215-228
36. Namati E, Chon D, Thiesse J, Hoffman EA, de Ryk J, Ross A, et al. In vivo micro-CT lung imaging via a computer-controlled intermittent iso-pressure breath hold (IIBH) technique. Phys Med Biol 2006; 51:6061-6075